News on The Associated Press

A.M. Vitals: J&J Aims to Step Into Blood-Thinner Market

2010-11-29T15:01:28Z

...

Oct. 14, 2010

2010-10-15T10:53:26Z

...

A.M. Vitals: Genzyme to Explore ‘Alternatives’ to Sanofi Bid

2010-10-11T15:13:43Z

...

A.M. Vitals: Sanofi Launches $69-Per-Share Hostile Bid for Genzyme

2010-10-04T06:33:43Z

...

A.M. Vitals: A Genetic Test Pegging the Odds of Living Past 100

2010-11-02T14:14:34Z

...

Risky drugs pulled from the market in recent years

2010-06-30T15:31:48Z

When a drug's risks exceed its benefits, the federal Food and Drug Administration may ask or order a company to withdraw it from the market, or a company may do so on its own. Here are some drugs withdrawn in recent years.

Mylotarg

Use: Acute myeloid leukemia

Risks: Liver disease

Manufacturer: Correction: Orexigen FDA Story

In a story March 31 about Orexigen Therapeutics, The Associated Press erroneously reported the name of a competitor. The company is Arena Pharmac...

THE INFLUENCE GAME: Drug lobby's health care win

2010-03-29T00:15:32Z

EDITOR'S NOTE — An occasional look at how influence is exercised in Washington.

By ALAN FRAM

Associated Press Writer

WASHINGTON (AP) — Chalk one up for the pharmaceutical lobby.

The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama's h...

Clarification: Amylin FDA info request story

2010-03-16T13:31:00Z

Clarification: Amylin FDA information request story

In a story March 15, The Associated Press reported that Bydureon is the proposed trade name of exenatide, a diabetes treatment being developed by Amylin Pharmaceuticals Inc., Associated Press Writer

WASHINGTON (AP) — With the nation's $46 billion biological drug market at stake, the war between makers of the pricey biotech medicines and their would-be generic competitors has involved millions of dollars in lobbying, thousands in campaign cont...

Health Highlights: April 22, 2009

2010-10-23T23:04:35Z

...

April 22, 2009

2010-10-23T23:09:48Z

...

FDA Reverses Stance on Removal of Morphine Painkiller

2010-10-23T22:37:32Z

...

Feb. 27, 2009

2010-10-23T21:09:56Z

...

1st Drug From Genetically Altered Animals Approved

2010-10-23T20:34:22Z

...

Lilly and Glaxo's Musical Chairs

2010-10-21T09:18:59Z

...

FDA Drug Approvals Inch Upward in 2008

2010-10-23T19:14:36Z

...

Indonesia to Drugmakers: Build Factories Here, Or Get Out

2010-10-23T19:14:03Z

...

Feds Mull Funding Drug Pitches to Counter Big Pharma

2010-10-22T23:04:46Z

...

Health Highlights: April 28, 2008

2010-10-23T09:56:33Z

...

Lilly's Lechleiter: Walker, Talker and Blogger

2010-10-22T23:03:03Z

...

Connecticut Sues Eli Lilly Over Zyprexa

2010-10-22T23:03:02Z

...

marketing of Zyprexa

2010-10-22T23:03:05Z

...

Lilly’s Lechleiter: Walker, Talker and Blogger

2010-10-22T23:03:05Z

...

Health Highlights: March 2, 2008

2010-10-23T09:55:50Z

...

Drug Industry Hikes Lobbying--for Kids

2010-10-22T23:02:12Z

...

Drug Industry Hikes Lobbying-for Kids

2010-10-22T23:02:35Z

...

Minn. law sheds light on drug companies

2010-09-09T15:52:20Z

Minn. Law Shines Rare Light Into Big Money Drug Companies Spend on State Advisory Panels

A groundbreaking Minnesota law is shining a rare light into the big money that drug companies spend on members of state advisory panels who help select which drugs are used in Medicaid programs for the poor and disabled.

Those panels, most comprised of physicians, hold great...

Minn. law shines rare light into big money drug companies spend on state advisory panels

2010-09-09T15:48:47Z

Those panels, most comprised of physicians, hold great sway over the $28 billion spent on drugs each year for Medicaid patients nationwide. But aside from Minnesota, o...

Health Highlights: July 27, 2007

2010-10-22T22:58:43Z

...

Nationals LaRoche Baseball

2011-01-04T21:31:22Z

In this April 7, 2010, photo, Arizona Diamondbacks first baseman Adam LaRoche catches a throw during a baseball game against the San Diego Padres in Phoenix. A person familiar with the negotiations tells Donna Lawlor shows Associated Press staffer Lynn Dombek as she pauses while snowshoeing up a hill on snow-covered logging roads in Hancock County, Maine. The solitude, q...

SC Legacy

2010-12-27T09:01:16Z

In this Tuesday, Dec. 14, 2010 photo, S.C. Gov. Mark Sanford talks with Associated Press reporters in his office in Columbia, S.C. about his time in office and his future. (AP Photo/Virginia Postic)

Austria Opera Gruberova

2010-12-27T06:01:18Z

In this photo taken Oct. 11, 2010, Soprano Edita Gruberova speaks during an interview with The Associated Press in Vienna, Austria. At the dizzying heights of her stellar operatic career, Gruberova has unexpectedly chosen to stoop and return to the role of the fallen woman who helped make her fame. Gruberova is not portraying just any wayward female. By rediscov...

Austria Edita Gruberova

2010-12-27T03:31:19Z

Edita Gruberova speaks during an interview with The Associated Press in Vienna, Austria, on Monday, Oct. 11, 2010. The 64-year-old SLovak diva sees no problem in returning to the role of a 20-something as Violetta Valery in Verdi's "La Tr...